Serracino-Inglott Ferdinand, Bray Alan E, Myers Paul
John Hunter Hospital, Newcastle, New South Wales, Australia.
J Vasc Surg. 2007 Aug;46(2):211-7. doi: 10.1016/j.jvs.2007.03.040.
To present our initial experience with the Zenith bifurcated iliac side branch device that preserves internal iliac artery flow whilst excluding aorto-iliac aneurysms.
Between November 2005 and October 2006, data was prospectively collected on 8 patients in whom this device was used; 2 aorto-bi-iliac aneurysms, 3 aorto-uni-iliac aneurysms, 1 solitary common iliac aneurysm, 1 distal type 1 endoleak, and 1 internal iliac aneurysm.
No mortality or major complications resulted from use of this device. The median fluoroscopy time was 53 minutes (range 38 to 105) and a median of 102 g of iodine (range 84 to 130) as contrast were used. One patient required a blood transfusion and only one of the eight side branches occluded. There has been no endoleak related to the device in the median follow-up period of 6 months (1 to 14 months).
This device provides an alternative for the management of patients with aorto-iliac aneurysms that is safe and less complex than, previously described, hybrid procedures that preserve internal iliac flow.
介绍我们使用保留髂内动脉血流同时排除主-髂动脉瘤的Zenith分叉髂侧支装置的初步经验。
在2005年11月至2006年10月期间,前瞻性收集了8例使用该装置患者的数据;其中2例主-双髂动脉瘤,3例主-单髂动脉瘤,1例孤立性髂总动脉瘤,1例远端I型内漏,1例髂内动脉瘤。
使用该装置未导致死亡或严重并发症。透视时间中位数为53分钟(范围38至105分钟),使用的造影剂碘中位数为102克(范围84至130克)。1例患者需要输血,8个侧支中仅1个闭塞。在6个月(1至14个月)的中位随访期内,未出现与该装置相关的内漏。
对于主-髂动脉瘤患者的治疗,该装置提供了一种替代方法,与先前描述的保留髂内血流的杂交手术相比,它安全且复杂性更低。